Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aripiprazole in schizophrenia: consensus guidelines.

M J Travis1, T Burns, S Dursun

  • 1Institute of Psychiatry, London, UK.

International Journal of Clinical Practice
|April 28, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trajectory of response to esketamine nasal spray for treatment resistant depression: findings from ESCAPE-TRD.

European psychiatry : the journal of the Association of European Psychiatrists·2026
Same author

Family History and Solar Insolation in Bipolar I Disorder.

Acta psychiatrica Scandinavica·2026
Same author

Consensus on Subdomains and Measures of Relevance to Affective and Social Cognition Research on Bipolar Disorder (CAS-BD); Outcomes and Recommendations From an International Society for Bipolar Disorders Targeting Cognition Taskforce Study.

Bipolar disorders·2026
Same author

The role of plasma inflammatory markers in late-life depression and conversion to dementia: a 3-year follow-up study.

Molecular psychiatry·2025
Same author

A stratified treatment algorithm in psychiatry: a program on stratified pharmacogenomics in severe mental illness (Psych-STRATA): concept, objectives and methodologies of a multidisciplinary project funded by Horizon Europe.

European archives of psychiatry and clinical neuroscience·2024
Same author

A systematic review of interventions in the early course of bipolar disorder I or II: a report of the International Society for Bipolar Disorders Taskforce on early intervention.

International journal of bipolar disorders·2023
Same journal

RETRACTION: Prediction of Arrhythmia Recurrence after Atrial Fibrillation Ablation in Patients with Normal Anatomy of the Left Atrium.

International journal of clinical practice·2025
Same journal

Clinical Outcomes Based on the Attainment of Low-Density Lipoprotein Cholesterol Targets in Patients with Acute Coronary Syndrome in Real-World Practice.

International journal of clinical practice·2025
Same journal

Knowledge and Awareness of Osteoporosis: A Survey of Physical Therapy Providers in Saudi Arabia.

International journal of clinical practice·2024
Same journal

Efficacy and Safety of Pericapsular Nerve Group Block for Hip Fracture Surgery under Spinal Anesthesia: A Meta-Analysis.

International journal of clinical practice·2024
Same journal

The Role of Pharmaceutical Innovation in Clinical Practice Guidelines for Chronic Diseases.

International journal of clinical practice·2024
Same journal

Blood Features Associated with Viral Infection Severity: An Experience from COVID-19-Pandemic Patients Hospitalized in the Center of Iran, Yazd.

International journal of clinical practice·2024
See all related articles

Aripiprazole offers a new atypical antipsychotic option for schizophrenia treatment. These UK guidelines detail best practices for its prescribing and use, addressing limitations of older medications.

Area of Science:

  • Psychiatry
  • Pharmacology

Background:

  • Schizophrenia necessitates long-term antipsychotic treatment.
  • Conventional antipsychotics cause side effects like extrapyramidal symptoms.
  • Atypical antipsychotics offer an alternative but have their own side effects, including weight gain, sedation, and hyperprolactinemia.

Framework:

  • Aripiprazole is a novel atypical antipsychotic agent.
  • It presents a new option for managing schizophrenia.
  • Guidelines are based on consensus from the Schizophrenia Innovation Working Group.

Implementation:

  • Focuses on best practices for prescribing aripiprazole.
  • Outlines appropriate use within the UK context.
  • Addresses the need for alternative treatment options due to limitations of existing medications.

Related Experiment Videos

Implications:

  • Provides clinicians with guidance on a new therapeutic option.
  • Aims to optimize the management of schizophrenia with aripiprazole.
  • Contributes to informed prescribing decisions for antipsychotic medications.